CRP group (n=73) | Communication group (n=73) | Combined group (n=83) | |||||||
---|---|---|---|---|---|---|---|---|---|
Baseline (mean (SD)) | Follow-up (mean (SD)) | Effect size (Cohen’s d)a | Baseline (mean (SD)) | Follow-up (mean (SD)) | Effect size (Cohen’s d) | Baseline (mean (SD)) | Follow-up (mean (SD)) | Effect size (Cohen’s d) | |
Importance of reducing prescribing | 6.03b (1.27) | 6.22 (1.00) | .15 | 5.85 (1.43) | 6.34 (0.89) | .35** | 5.90 (1.08) | 6.25 (1.05) | .27* |
Risks of reducing prescribing | 4.37 (1.56) | 4.88 (1.37) | .31* | 4.81 (1.61) | 5.16 (1.45) | .19 | 4.33 (1.47) | 4.76 (1.50) | .23* |
Risk to relationship with patients | 4.49 (1.62) | 4.63 (1.58) | .08 | 4.74 (1.80) | 4.89 (1.61) | .08 | 4.76 (1.41) | 5.12 (1.33) | .25* |
Confidence to reduce prescribing | 4.89 (1.49) | 4.64 (1.49) | -.13 | 4.71 (1.79) | 5.12 (1.70) | .21 | 4.86 (1.50) | 5.28 (1.35) | .25* |